Venous thromboembolism was present in 73 patients (12.2%), with 68 cases of pulmonary embolism diagnosed immediately after referral. ... Venous thromboembolism occurred in 52 patients with a Wells score of greater than 4 (29.5%; 95% CI, 22.9% to 36.9%).
Pregnant women who are admitted to the hospital for reasons not related to delivery have a higher risk of first venous thromboembolism, a new study found. ... Within this group, they retrieved information on admissions that lasted at least one day,
All-cause mortality was not significantly different between these groups (adjusted OR, 0.78; 95% CI, 0.50 to 1.22; P=0.28), nor were rates of recurrent venous thromboembolism
Intermittent pneumatic compression (IPC) to the lower limbs can reduce venous thromboembolism (VTE) risk in hospitalized patients and is especially effective when combined with pharmacologic thromboprophylaxis, a new meta-analysis found. ... to the IPC
Hospitals that have higher rates of pharmacologic prophylaxis for venous thromboembolism (VTE) don't have lower rates of VTE, a new study found.
Rosiglitazone restricted to patients who can't take other drugs. Antipsychotic drugs may increase risk for venous thromboembolism (VTE), especially in new users, according to a new study. ... The authors identified 25,532 eligible cases, 15,975 with deep
Adverse outcomes, including return visits for PE-related symptoms within five days and recurrent venous thromboembolism, major hemorrhage, and all-cause mortality within 30 days, were also evaluated.
Acute venous thromboembolism treatment, flu vaccines, and more. Fixed-dose treatment with apixaban was noninferior to conventional therapy for acute venous thromboembolism (VTE) and appeared to be associated with significantly less ... However, they
Feldman. Patients who have a venous thromboembolism are often given an array of tests, many of which are unlikely to affect their treatment but can cause negative consequences.“ I've seen
22.9%), clinical signs or symptoms of deep venous thrombosis (40.2% vs. ... 4.5%), previous venous thromboembolism (11.3% vs. 4.3%), and active cancer (19.6% vs.